David Matuskey1, Gustavo A Angarita2, Patrick Worhunsky3, Sheida Koohsari4, Paul Gravel4, Brian Pittman3, Edward C Gaiser4, Jean-Dominque Gallezot4, Nabeel Nabulsi4, Yiyun Huang4, Richard E Carson4, Marc N Potenza5, Robert T Malison2. 1. Department of Radiology and Biomedical Imaging, Yale University, New Haven, CT, United States; Department of Psychiatry, Yale University, New Haven, CT, United States; Department of Neurology, Yale University, New Haven, CT, United States. Electronic address: david.matuskey@yale.edu. 2. Department of Psychiatry, Yale University, New Haven, CT, United States; Connecticut Mental Health Center, New Haven, CT, United States. 3. Department of Psychiatry, Yale University, New Haven, CT, United States. 4. Department of Radiology and Biomedical Imaging, Yale University, New Haven, CT, United States. 5. Department of Psychiatry, Yale University, New Haven, CT, United States; Connecticut Mental Health Center, New Haven, CT, United States; Connecticut Council on Problem Gambling, Wethersfield, CT, United States; Department of Neuroscience, Yale University, New Haven, CT, United States.
Abstract
BACKGROUND: Positron emission tomography (PET) work with the dopamine D3 receptor (D3R) preferring ligand [11C]PHNO in obese individuals has demonstrated higher binding and positive correlations with body mass index (BMI) in otherwise healthy individuals. These findings implicated brain reward areas including the substantia nigra/ventral tegmental area (SN/VTA) and pallidum. In cocaine use disorder (CUD), similar SN/VTA binding profiles have been found compared to healthy control subjects. This study investigates whether BMI-[11C]PHNO relationships are similar in individuals with CUD. METHODS: Non-obese CUD subjects (N = 12) were compared to age-matched obese CUD subjects (N = 14). All subjects underwent [11C]PHNO acquisition using a High Resolution Research Tomograph PET scanner. Parametric images were computed using the simplified reference tissue model with cerebellum as the reference region. [11C]PHNO measures of receptor availability were calculated and expressed as non-displaceable binding potential (BPND). RESULTS: In between-group analyses, D2/3R availability in non-obese and obese CUD groups was not significantly different overall. BMI was inversely correlated withBPND in the SN/VTA (r = -0.45, p = 0.02 uncorrected) in all subjects. CONCLUSION: These data suggest that obesity in CUD was not associated with significant differences in D2/3R availability. This in contrast to previous findings in non-CUD individuals that found increased availability of D3Rs in the SN/VTA associated with obesity. These findings could potentially reflect dysregulation of D3R in CUD, impacting how affected individuals respond to natural stimuli such as food.
BACKGROUND: Positron emission tomography (PET) work with the dopamine D3 receptor (D3R) preferring ligand [11C]PHNO in obese individuals has demonstrated higher binding and positive correlations with body mass index (BMI) in otherwise healthy individuals. These findings implicated brain reward areas including the substantia nigra/ventral tegmental area (SN/VTA) and pallidum. In cocaine use disorder (CUD), similar SN/VTA binding profiles have been found compared to healthy control subjects. This study investigates whether BMI-[11C]PHNO relationships are similar in individuals with CUD. METHODS: Non-obese CUD subjects (N = 12) were compared to age-matched obese CUD subjects (N = 14). All subjects underwent [11C]PHNO acquisition using a High Resolution Research Tomograph PET scanner. Parametric images were computed using the simplified reference tissue model with cerebellum as the reference region. [11C]PHNO measures of receptor availability were calculated and expressed as non-displaceable binding potential (BPND). RESULTS: In between-group analyses, D2/3R availability in non-obese and obese CUD groups was not significantly different overall. BMI was inversely correlated withBPND in the SN/VTA (r = -0.45, p = 0.02 uncorrected) in all subjects. CONCLUSION: These data suggest that obesity in CUD was not associated with significant differences in D2/3R availability. This in contrast to previous findings in non-CUD individuals that found increased availability of D3Rs in the SN/VTA associated with obesity. These findings could potentially reflect dysregulation of D3R in CUD, impacting how affected individuals respond to natural stimuli such as food.
Authors: N Tzourio-Mazoyer; B Landeau; D Papathanassiou; F Crivello; O Etard; N Delcroix; B Mazoyer; M Joliot Journal: Neuroimage Date: 2002-01 Impact factor: 6.556
Authors: David Matuskey; Patrick Worhunksy; Elizabeth Correa; Brian Pittman; Jean-Dominique Gallezot; Nabeel Nabulsi; Jim Ropchan; Venkatesh Sreeram; Rohit Gudepu; Edward Gaiser; Kelly Cosgrove; Yu-Shin Ding; Marc N Potenza; Yiyun Huang; Robert T Malison; Richard E Carson Journal: Neuroimage Date: 2016-02-11 Impact factor: 6.556
Authors: Isabelle Boileau; Doris Payer; Sylvain Houle; Arian Behzadi; Pablo M Rusjan; Junchao Tong; Diana Wilkins; Peter Selby; Tony P George; Martin Zack; Yoshiaki Furukawa; Tina McCluskey; Alan A Wilson; Stephen J Kish Journal: J Neurosci Date: 2012-01-25 Impact factor: 6.167
Authors: Romina Mizrahi; Ofer Agid; Carol Borlido; Ivonne Suridjan; Pablo Rusjan; Sylvain Houle; Gary Remington; Alan A Wilson; Shitij Kapur Journal: Schizophr Res Date: 2011-09 Impact factor: 4.939
Authors: Diana Martinez; Allegra Broft; Richard W Foltin; Mark Slifstein; Dah-Ren Hwang; Yiyun Huang; Audrey Perez; W Gordon Frankle; Thomas Cooper; Herbert D Kleber; Marian W Fischman; Marc Laruelle; W Gordon Frankel Journal: Neuropsychopharmacology Date: 2004-06 Impact factor: 7.853
Authors: Jean-Dominique Gallezot; Ming-Qiang Zheng; Keunpoong Lim; Shu-fei Lin; David Labaree; David Matuskey; Yiyun Huang; Yu-Shin Ding; Richard E Carson; Robert T Malison Journal: J Nucl Med Date: 2014-04-14 Impact factor: 10.057
Authors: Patrick D Worhunsky; David Matuskey; Jean-Dominique Gallezot; Edward C Gaiser; Nabeel Nabulsi; Gustavo A Angarita; Vince D Calhoun; Robert T Malison; Marc N Potenza; Richard E Carson Journal: Neuroimage Date: 2017-01-19 Impact factor: 6.556